What is an integrated evidence plan (IEP)?
An IEP is a cross-functional roadmap that identifies the key data needed to support regulatory, market access, medical, and commercial objectives. It includes timelines for clinical trials, HEOR studies, real-world evidence, and publication activities. The IEP aligns internal teams around a shared vision of how and when evidence will be developed and used.
Why is an IEP important in pharmaceutical development?
An IEP ensures that the right evidence is available at the right time to inform decision-making and stakeholder engagement. It reduces duplication, increases efficiency, and provides a framework for integrated planning across medical affairs, market access, and clinical development.
